Online video campaign ‘gives life’ to powerful Parkinson’s stories
Author: Geoffrey ChangPublished: 13 August 2015
Prep: Cook: Serves:
Sometimes a story needs more than just words on a page
A non-profit organisation has dedicated its 2015 campaign to raising international awareness of Parkinson’s through a collection of inspiring crowd-sourced videos.
Based in New York, the charity – My Angel My Hero – is appealing to those living with Parkinson’s to submit videos describing their personal journeys, the highs and the lows.
By encouraging people to share their stories, the campaign is aiming to inspire, empower and spread hope for others tackling the disease. The charity hopes to create a library of at least 200 online videos within the first year.
The charity has assembled a team of 25 volunteers from, video editors to development professionals to lawyers, to join in the humanitarian efforts.
Faizan Sheikh, founder of My Angel My Hero, said: “My Angel My Hero’s mission is to give life to stories through videos and films. We believe every moment is a story. Every story has a message. In phase one of our 2015 campaign, we’ll offer people affected by Parkinson’s the opportunity to be heard.”
The name of the campaign comes from a film that Sheikh made about a promising young dancer who is diagnosed with young onset Parkinson’s, a story inspired by real life events. He began to encourage others facing Parkinson’s to recount their experience on camera, giving rise to this latest online campaign.
Frankie Smith, a retired maths teacher diagnosed with Parkinson’s at 53, learned about My Angel My Hero in a chat room. In her video testimonial she says: “Every day I wake up, and I have a sense of gratitude. I hope that as my Parkinson’s gets worse and as I meet each new challenge, I continue to have an attitude of thankfulness and a choice to be happy.”
About My Angel My Hero
My Angel My Hero is a 501(3)(c) non-profit organisation committed to raising awareness for various social, medical and charitable causes including Parkinson’s disease, autism and domestic violence. What began as an idea to help patients tell their stories has grown into a full team of volunteers and community members that is rooted in compassion, growth and advocacy.
Football stars sign up for Parkinson’s ‘tremor’ campaign
Athletic Bilbao players appear in a viral video
3 weeks ago
Excess calcium in brain could cause Parkinson’s
Researchers at the University of Cambridge, UK, have discovered that excess levels of calcium in brain cells may lead to the formation of the toxic clusters that signify Parkinson’s disease. The findings, reported in the journal ‘Nature Communications’, show that calcium can influence the interaction between small membranous structures inside nerve endings, which are important for neuronal signaling in the brain, and alpha-synuclein – the protein associated with Parkinson’s disease. Dr Janin Lautenschläger, the paper’s first author, said: “This is the first time we’ve seen that calcium influences the way alpha-synuclein interacts with synaptic vesicles. We think that alpha-synuclein is almost like a calcium sensor. In the presence of calcium, it changes its structure and how it interacts with its environment, which is likely very important for its normal function.”
Jewish people with Crohn’s disease more likely to carry LRRK2 gene mutation
A scientific study has concluded that there may be a link between Parkinson’s and Crohn’s disease within the Ashkenazi Jewish community. The study’s findings, which were published in the journal ‘Science Translational Medicine’, has found that members of the population with Crohn’s disease are more likely to carry the LRRK2 mutation which is a significant cause of Parkinson’s. Lead researcher Dr Inga Peter, professor of genetics and genomic sciences at the Icahn School of Medicine, New York, US, said: “Crohn’s disease is a complex disorder with multiple genes and environmental factors involved, which disproportionately affects individuals of Ashkenazi Jewish ancestry. “The presence of shared LRRK2 mutations in patients with Crohn’s disease and Parkinson’s disease provides refined insight into disease mechanisms and may have major implications for the treatment of these two seemingly unrelated diseases.”
Could caffeine in the blood help diagnose Parkinson’s?
Blood caffeine levels could be promising diagnostic biomarkers for early-stage Parkinson’s, Japanese researchers reported in the journal ‘Neurology’ earlier this month. The study found that people with Parkinson’s had lower levels of caffeine and caffeine metabolites in their blood than people without the disease, at the same consumption rate. Caffeine concentrations also were decreased in Parkinson’s patients with motor fluctuations than in those without Parkinson’s. However, patients in more severe disease stages did not have lower caffeine levels. The study’s authors, Dr David Munoz, University of Toronto, and Dr Shinsuke Fujioka, Fukuoka University, suggested that the “decrease in caffeine metabolites occurs from the earliest stages of Parkinson’s.” They added: “If a future study were to demonstrate similar decreases in caffeine in untreated patients with Parkinson’s […] the implications of the current study would take enormous importance.”